Dr Ewa Gogola from the Patel Group in the MRC Molecular Haematology Unit has been awarded funding by the Wellcome Trust for the project \u2018DNA damage-induced hepatocyte polyploidisation- how it happens and what are its consequences?\u2019
Up to $30 million in funding has been announced by the Coalition for Epidemic Preparedness Innovations (CEPI) to bring a new nanoparticle vaccine offering protection against a range of coronaviruses to clinical trial.
Seven academics in Oxford have been named National Institute of Health Research (NIHR) Senior Investigators in recognition of their outstanding leadership in research.
A collaboration between researchers at the MRC WIMM/RDM and Department of Earth Sciences uncovers the importance of iron for the development of complex life on Earth.
Study from the Dong Group reveals key differences in the adaptive immune responses of patients with mild vs. severe COVID-19, highlighting a potential new vaccine target.
A new study from the Patel Group sheds light on the mechanism by which DNA damage suppresses appetite, a finding with implications for understanding the appetite lowering side-effects of chemotherapy.
The Lymph nodE single-cell Genomics AnCestrY (LEGACY) Network will create an ethnically diverse single-cell atlas of the response to commonly used vaccines such as flu vaccines with a focus on responses in lymph nodes.
![\"\"](\"https://www.rdm.ox.ac.uk/news/congratulations-to-tom-milne-and-ross-chapman-on-becoming-full-professors/responsive_image?ratio=r16x9&scale=w760\")
\n \n \n\n\n